Elucidating the mechanisms of formononetin in modulating atherosclerotic plaque formation in ApoE-/- mice.

"Declarations Ethics approval and consent to participateAll animal experiments were approved by the Institutional Animal Care of Traditional Chinese Medicine (approval number: 776). The study was performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and this study was carried out in compliance with the ARRIVE guidelines. Consent for publicationNot applicable. Competing interestsThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"Funding This study was supported by the National Natural Science Foundation of China (Grant No. 82160850) and the Science and Technology Foundation of Guizhou Province (Grant No. Qiankehe Jichu[2020]1Z071)."